Cercano Management LLC Takes Position in Danaher Corporation $DHR

Cercano Management LLC bought a new stake in Danaher Corporation (NYSE:DHRFree Report) during the 4th quarter, HoldingsChannel.com reports. The fund bought 56,232 shares of the conglomerate’s stock, valued at approximately $12,873,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. JPL Wealth Management LLC acquired a new position in shares of Danaher in the third quarter valued at about $25,000. Elevated Capital Advisors LLC purchased a new stake in Danaher in the fourth quarter valued at approximately $26,000. WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners purchased a new position in Danaher during the 3rd quarter worth approximately $32,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 1.4%

DHR stock opened at $180.07 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a 50-day moving average of $181.91 and a two-hundred day moving average of $207.20. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a market cap of $127.45 billion, a price-to-earnings ratio of 34.83, a PEG ratio of 2.44 and a beta of 0.81.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the company earned $1.88 EPS. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. As a group, analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analyst Ratings Changes

DHR has been the subject of a number of research reports. Robert W. Baird lowered their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a report on Friday, April 17th. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Jefferies Financial Group reaffirmed a “buy” rating and set a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. Finally, Rothschild & Co Redburn set a $205.00 price target on Danaher in a research report on Friday, April 17th. Nineteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $238.24.

Read Our Latest Stock Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.